Emergent BioSolutions (EBS) Tops Q3 EPS by 28c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.04 -1.71%
Revenue Growth %: +32.0%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +32.0%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $0.83, $0.28 better than the analyst estimate of $0.55. Revenue for the quarter came in at $164.9 million versus the consensus estimate of $151.42 million.
Emergent BioSolutions sees FY2015 revenue of $510-540 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
